JAMA:补充维生素D 对膝关节骨性关节炎症状无益
2013-01-21 JAMA cmt 吴君德 编译
一项持续两年的美国研究显示,补充维生素D使血浆1,25 -二羟维生素D水平>36 ng/ml,并不能改善有症状的膝关节骨性关节炎(OA)患者的膝痛或软骨体积减少。论文发表于《美国医学会杂志》[JAMA 2013,309(2):155]。 研究纳入146例有症状的膝关节OA患者,随机给予安慰剂或维生素D3(2000 IU/d),并递增剂量使患者血浆1
一项持续两年的美国研究显示,补充维生素D使血浆1,25 -二羟维生素D水平>36 ng/ml,并不能改善有症状的膝关节骨性关节炎(OA)患者的膝痛或软骨体积减少。论文发表于《美国医学会杂志》[JAMA 2013,309(2):155]。
研究纳入146例有症状的膝关节OA患者,随机给予安慰剂或维生素D3(2000 IU/d),并递增剂量使患者血浆1,25 -二羟维生素D水平>36 ng/ml。研究采用西安大略和麦克马斯特大学(WOMAC)疼痛量表评价膝痛程度,并用磁共振成像测量软骨体积减少程度。结果显示,研究组与对照组膝痛评分分别降低了2.31和1.46,无显著差异;两组软骨体积减少程度也相似。
Importance Knee osteoarthritis (OA), a disorder of cartilage and periarticular bone, is a public health problem without effective medical treatments. Some studies have suggested that vitamin D may protect against structural progression.
Objective To determine whether vitamin D supplementation reduces symptom and structural progression of knee OA.
Design, Setting, and Patients A 2-year randomized, placebo-controlled, double-blind, clinical trial involving 146 participants with symptomatic knee OA (mean age, 62.4 years [SD, 8.5]; 57 women [61%], 115 white race [79%]). Patients were enrolled at Tufts Medical Center in Boston between March 2006 and June 2009.
Intervention Participants were randomized to receive either placebo or oral cholecalciferol, 2000 IU/d, with dose escalation to elevate serum levels to more than 36 ng/mL.
Main Outcome Measures Primary outcomes were knee pain severity (Western Ontario and McMaster Universities [WOMAC] pain scale, 0-20: 0, no pain; 20, extreme pain), and cartilage volume loss measured by magnetic resonance imaging. Secondary end points included physical function, knee function (WOMAC function scale, 0-68: 0, no difficulty; 68, extreme difficulty), cartilage thickness, bone marrow lesions, and radiographic joint space width.
Results Eighty-five percent of the participants completed the study. Serum 25-hydroxyvitamin D levels increased by a mean 16.1 ng/mL (95% CI, 13.7 to 18.6) in the treatment group and by a mean 2.1 mg/mL (95% CI, 0.5 to 3.7) (P < .001) in the placebo group. Baseline knee pain was slightly worse in the treatment group (mean, 6.9; 95% CI, 6.0 to 7.7) than in the placebo group (mean, 5.8; 95% CI, 5.0 to 6.6) (P = .08). Baseline knee function was significantly worse in the treatment group (mean, 22.7; 95% CI, 19.8 to 25.6) than in the placebo group (mean, 18.5; 95% CI, 15.8 to 21.2) (P = .04). Knee pain decreased in both groups by a mean −2.31 (95% CI, −3.24 to −1.38) in the treatment group and −1.46 (95% CI, −2.33 to −0.60) in the placebo group, with no significant differences at any time. The percentage of cartilage volume decreased by the same extent in both groups (mean, −4.30; 95% CI, −5.48 to −3.12 vs mean, −4.25; 95% CI, −6.12 to −2.39) (P = .96). There were no differences in any of the secondary clinical end points.
Conclusion and Relevance Vitamin D supplementation for 2 years at a dose sufficient to elevate 25-hydroxyvitamin D plasma levels to higher than 36 ng/mL, when compared with placebo, did not reduce knee pain or cartilage volume loss in patients with symptomatic knee OA.
作者:JAMA
版权声明:
本网站所有注明“来源:梅斯医学”或“来源:MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明“来源:梅斯医学”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
????!
183
国内做得很难
125
#关节炎#
55
#膝关节骨性关节炎#
49